Table 2 Comparing variables with and without adverse events during exchange transfusion
Adverse event | Variables | No | Yes | P value |
|---|---|---|---|---|
Hyperglycemia 162 (86.2%) | ABO incompatibility | 15(57.7%) | 50(30.9%) | 0.014 |
ET time | 104.88 ± 20.81 | 95.47 ± 18.22 | 0.017 | |
ET artery axillary | 5(19.2%) | 5(3.1%) | 0.003 | |
Serum potassium | 3.87 ± 0.39 | 3.65 ± 0.53 | 0.046 | |
Cerebral hemorrhage | 1(3.8%) | 42(25.9%) | 0.025 | |
Top-up transfusion after et 95 (50.5%) | Admission age | 7.00 ± 4.04 | 5.85 ± 3.83 | 0.046 |
Etiology unidentified | 57(61.3%) | 39(41.1%) | 0.009 | |
IBIL at admission | 431.34 ± 99.24 | 394.97 ± 113.56 | 0.021 | |
TBILbga at admissiona | 528.25 ± 111.54 | 465.65 ± 122.34 | < 0.001 | |
TBILbga before ET | 407.01 ± 107.13 | 370.78 ± 105.68 | 0.021 | |
Hemoglobin | 142.83 ± 33.67 | 121.18 ± 29.40 | < 0.001 | |
Hypocalcemia 80 (42.6%) | Admission age | 7.51 ± 3.64 | 4.94 ± 3.93 | < 0.001 |
Breast feeding | 76(70.4%) | 37(46.2%) | 0.001 | |
Formula feeding | 9(8.3%) | 21(26.2%) | 0.002 | |
No feeding | 0(0.0%) | 7(8.8%) | 0.006 | |
RH incompatibility | 3(2.8%) | 18(22.5%) | < 0.001 | |
G6PD deficiency | 25(23.1%) | 5(6.2%) | 0.003 | |
Etiology unidentified | 64(59.3%) | 32(40.0%) | 0.014 | |
ET time | 99.31 ± 19.56 | 93.35 ± 17.32 | 0.032 | |
ET speed | 5.09 ± 0.93 | 5.44 ± 1.02 | 0.014 | |
ET artery femoral | 21(19.4%) | 29(36.2) | 0.016 | |
TBILbga at admission | 528.69 ± 95.60 | 453.31 ± 137.64 | < 0.001 | |
TBILbga before ET | 409.50 ± 103.33 | 360.62 ± 107.63 | 0.002 | |
Serum bicarbonate | 21.83 ± 2.60 | 20.64 ± 2.71 | 0.003 | |
White cell count | 12.97 ± 4.77 | 17.01 ± 10.59 | 0.001 | |
Hyponatremia 80 (42.6%) | ABO incompatibility | 45(41.7%) | 20(25.0%) | 0.026 |
ET vein femoral | 21(19.4%) | 5(6.2%) | 0.017 | |
Bilirubin exchange rate | 0.46 ± 0.11 | 0.51 ± 0.08 | 0.004 | |
Thrombocytopenia 72 (38.3%) | Admission age | 6.93 ± 4.14 | 5.58 ± 3.55 | 0.023 |
TBIL at admission | 453.56 ± 119.07 | 403.52 ± 102.60 | 0.004 | |
TBILbga Before ET | 404.76 ± 109.88 | 362.83 ± 99.35 | 0.009 | |
Hemoglobin | 137.72 ± 32.73 | 122.49 ± 32.29 | 0.002 | |
Metabolic acidosis 48 (25.5%) | Gravidity | G2(34.8%);G3(15.6%) | G2(13.3%);G3(31.1%) | 0.021 |
Not feeding | 2 (1.4%) | 5 (10.4%) | 0.017 | |
ABO incompatibility | 40(28.6%) | 25(52.1%) | 0.005 | |
Serum calcium | 1.17 ± 0.12 | 1.13 ± 0.11 | 0.025 | |
White cell count | 13.98 ± 6.92 | 16.75 ± 10.43 | 0.039 | |
Hypokalemia 48 (25.5%) | Sex (female) | 50(35.7%) | 26(54.2%) | 0.038 |
Admission age | 7.00 ± 3.98 | 4.73 ± 3.42 | 0.001 | |
Breast feeding | 91(65.0%) | 22(45.8%) | 0.030 | |
G6PD deficiency | 28(20.0%) | 2(4.2%) | 0.018 | |
ET vein popliteal | 20(14.5%) | 0(0.0%) | 0.010 | |
TBILbga before ET | 398.06 ± 105.39 | 361.42 ± 110.65 | 0.042 | |
Serum calcium | 1.18 ± 0.11 | 1.11 ± 0.14 | 0.001 |